Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma

Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma

Εμφάνιση άλλων εκδόσεων (1)

Background Eosinophilic airway inflammation measured by using induced sputum is an important treatment stratification tool in patients with severe asthma. In addition, sputum eosinophilia has been shown to be associated with severe exacerbations and airflow limitation. Objectives We sought to identi...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Newby, C, Agbetile, J, Hargadon, B, Monteiro, W, Green, R, Pavord, I, Brightling, C, Siddiqui, S
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Mosby Inc. 2014

Παρόμοια τεκμήρια

Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
ανά: Newby, C, κ.ά.
Έκδοση: (2014)

Temporal assessment of airway remodeling in severe asthma using quantitative computed tomography.
ανά: Gupta, S, κ.ά.
Έκδοση: (2015)

Eosinophils in asthma and airway hyperresponsiveness.
ανά: Brightling, C, κ.ά.
Έκδοση: (2004)

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.
ανά: Fairs, A, κ.ά.
Έκδοση: (2010)

Multiple inflammatory hits and the pathogenesis of severe airway disease.
ανά: Pavord, I, κ.ά.
Έκδοση: (2006)

The significance of eosinophilic airway inflammation in asthma
ανά: Pavord, I, κ.ά.
Έκδοση: (2002)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
ανά: Shaw, D, κ.ά.
Έκδοση: (2007)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
ανά: Green, R, κ.ά.
Έκδοση: (2006)

Exacerbations of severe asthma in patients treated with mepolizumab
ανά: Shrimanker, R, κ.ά.
Έκδοση: (2018)

New insights into the relationship between airway inflammation and asthma.
ανά: Wardlaw, A, κ.ά.
Έκδοση: (2002)

Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2005)

Location, location, location: microlocalisation of inflammatory cells and airway dysfunction.
ανά: Brightling, C, κ.ά.
Έκδοση: (2004)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2003)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
ανά: Wardlaw, A, κ.ά.
Έκδοση: (2004)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
ανά: Haldar, P, κ.ά.
Έκδοση: (2014)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
ανά: Haldar, P, κ.ά.
Έκδοση: (2014)

Mast-cell infiltration of airway smooth muscle in asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2002)

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
ανά: Agbetile, J, κ.ά.
Έκδοση: (2014)

Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study)
ανά: Agbetile, J, κ.ά.
Έκδοση: (2014)

Variability in airway inflammation, symptoms, lung function and reliever use in asthma: anti-inflammatory reliever hypothesis and STIFLE study design
ανά: Tim Harrison, κ.ά.
Έκδοση: (2020-06-01)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
ανά: Bilocca, D, κ.ά.
Έκδοση: (2017)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2005)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
ανά: Haldar, P, κ.ά.
Έκδοση: (2014)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
ανά: Haldar, P, κ.ά.
Έκδοση: (2009)

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
ανά: Agbetile, J, κ.ά.
Έκδοση: (2012)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
ανά: Kulkarni, N, κ.ά.
Έκδοση: (2010)

Eosinophils in Asthma and Airway Hyperresponsiveness [3] (multiple letters)
ανά: Brightling, C, κ.ά.
Έκδοση: (2004)

Biomarkers predicting response to corticosteroid therapy in asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2005)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
ανά: Shrimanker, R, κ.ά.
Έκδοση: (2017)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
ανά: Green, R, κ.ά.
Έκδοση: (2002)

Qualitative analysis of high-resolution CT scans in severe asthma.
ανά: Gupta, S, κ.ά.
Έκδοση: (2009)

Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma
ανά: Desai Dhananjay, κ.ά.
Έκδοση: (2013-02-01)

Asthma control, airway responsiveness and airway inflammation.
ανά: Pavord, I
Έκδοση: (2009)

Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.
ανά: Bafadhel, M, κ.ά.
Έκδοση: (2010)

The upper and lower airway microbiome in severe asthma
ανά: Jabeen, M, κ.ά.
Έκδοση: (2022)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
ανά: Siva, R, κ.ά.
Έκδοση: (2007)

A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.
ανά: Shaw, D, κ.ά.
Έκδοση: (2012)

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.
ανά: Gupta, S, κ.ά.
Έκδοση: (2010)

Stability of inflammatory phenotypes in asthma.
ανά: Green, R, κ.ά.
Έκδοση: (2012)

Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
ανά: Lucia De Prado Gomez, κ.ά.
Έκδοση: (2023-03-01)